Duke U. Ple~licdl Center, Dept. of Peds, Durham, N.C. 411 g i r l s age 11 arid under presenting t o the pediatric c l i n i c betwee!.: 1978-iV86 vrltl? q e l l~t a l wartr were evaluated b y t h e Chi!d P r o t e i t l c n Team fal-c o i n i e c t~~i g STD's and sexual abuse. The 11 c h i l d r e n were 1.5-3 y r s i 5 ) , 3-6 yr.5 ! 1 I atlr! 6-11 y ! -% 5 . Ail had p e r i r e c t a i andlor perlvaginal h a r t s , diagnosed Ll y inspection (51 o r Diopsy ( 6 ) . 1\!1ne had conoyloma acuminatj ano two tlad crops of verrucd v u l g~l -1 5 . Nlne had t i n d i n g s l n d i c a t i v e uf sexual abuse ~ncluC!ng uischarge ( 5 ) , bleeding 5 8 , f a u l ado:-( 4 1 , hynjetial diameter . 13 mm ( 4 1 , and anal gaping (11. -.
h e -i~t . ; e r ! s ) o i 7 were identified. do g i r l s nbd m h~t i p~e '
anusers a~?a 3 otliel s were rlighly suspected t o havc-had mu1 t l p l c abusers. These 5 c h i l o r e n nad other c u i n f e c t ? n y STD's. Conclusion: Sexual trartsmlssion o i g e n i t a l warts 1 5 demonstrated i r~ 9 of tltr 11 q l r i s by a d d i t i o n a l i n n~r . a t o r x incibaing s t a t e m e n t s $7-om \.he c n l l d , physical evlde!ice, an0 c c~n f e c t , l~i i ; STD's. Cni1rl1-en w i t t i g e n i t a l wat t s sliould be evaluated f o r other STD's ano sexual abuse. Coinier t i n g STD's way be an indicator of mL,itiple abusers ill cI1110rezi wlth g e~i ta! warts. W e posculate t h a t t h e a f f i n i t y of antibody a g a i n s t p o l y r i b o s y l r i b i c o l phosphate (PRP) may be a s important a s c o n c e n t r a t i o n i n h o s t defense a g a i n s t Haemophilus i n f l u e n z a e b (liib), and may d i f f e r f o r T-independent and T-dependent a n t i g e n s . Using o l i g o s a c c h a r i d e s (0s) from Hib we measured t h e i n t r i n s i c a f i i n i t y (K) of a n t i g e n antibody binding r a t h e r t h a n t h e r e l a t i v e a v i d i t y of antibody f o r m u l t i v a l e n t antigen. PRP-OS were produced by a c i d h y d r o l y s i s and g e l f i l t r a t i o n ; s i z e d according t o t h e number of r e p e a t i n g u n i t s (TIR); and r a d i o l a b e l l e d . A f f i n i t i e s of p u r i f i e d b a c t e r i a l polysaccharide hyperimmune g l o b u l i n (BPIG) and of s e r a from vaccinated a d u l t donors were measured by a modified F a r r a s s a y , and t h e t o t a l antibody binding s i t e s (Abt) c a l c u l a t e d . BPIG bound t o OS of T/R=4, 3 and 2 with K=3.5, 2.3 and 1 . 5~1 0~ M-l r e s p e c t i v e l y , while Abt was c o n s t a n t .
Serum from t e n a d u l t s vaccinated with one dose of PRP-di h t h e r i a P toxoid conjugate (PRP-D) had a n average ~= 5 . 1~4 . 1~1 0~ M-, compared t o n i n e PRP vaccinated s u b j e c t s w i t h a n average ~= 6 . 5 f 4 . 1~1 0~ 9 1 6 by a a n D. ~o g o l ) ~c h o o l s of Medicine, UYniversity of V i r g i n i a , C h a r l o t t e s v i l l e , VA and SUNYDownstate, Brooklyn, NY.
M-I (p>0.1). We conclude t h a t anti-PRP IgG binds PRP-OS w i t h low a f f i n i t y t h a t d e c r e a s e s w i t h t h e s i z e of 0 s . Since t o t a l antibody binding s i t e s d i d n o t vary by OS s i z e , t h e s e d a t a suggest t h a t t h e r e were no subpopulations of antibody w i t h binding r e s t r i c t e d by OS s i z e . F i n a l l y , t h e i n t r i n s i c a f f i n i t y of t h e primary antibody response i s s i m i l a r r e g a r d l e s s of v a c c i n a t i o n w i t h PRP o r PRP-D, though f u r t h e r s t u d i e s may show d i f f e r e n t a f f i n i t i e s w i t h secondary
I n t h e past, t h r e e methods have been used t o provide l a b o r a t o r y confirmation of t h e c l i n i c a l d i a g n o s i s of i n f e c t i o n with B. p e r t u s s i s (Bp)
Two new methods show promise i n p e r t u s s i s diagnosis. F i r s t , DNA h y b r i d i z a t i o n u s i n g a sequence highly r e p e a t e d i n t h e p e r t u s s i s genome can i d e n t i f y a s few a s 103 Bp i n nasopharyngeal (NP) s e c r e t i o n s . Second, Bp a d e n y l a t e c y c l a s e can be d e t e c t e d by enzymatic assay of t h e organisms a l s o i n NP s e c r e t i o n s . I n t h i s study, specimens from 21 c h i l d r e n w i t h cough and vomiting were evaluated f o r Bp i n f e c t i o n w i t h f i v e methods: 1 ) c u l t u r e ; 2 ) FA; 3 ) a g g l u t i n i n serology; 4 ) DNA h y b r i d i z a t i o n and 5) a d e n y l a t e c y c l a s e assay. A l l but one of t h e c h i l d r e n were < 1 y e a r of a g e and had r e c e
i v e d no DPT. 'hro o r more t e s t s were p o s i t i v e f o r g of t h e 21 p a t i e n t s . The s e n s i t i v i t i e s f o r i d e n t i f i c a t i o n of Bp i n f e c t i o n by t h e s e t e s t s
were: c u l t u r e , 44%; FA, 67%; a d e n y l a t e c y c l a s e 67% and DNA
probe 89%. These d a t a i n d i c a t e t h a t use of NP s e c r e t i o n s and
t h e r e c e n t l y developed DNA probe can provide a r a p i d and The g r e a t e s t r i s k f o r s e v e r e RSV d i s e a s e o c c u r s in c h i l d r e n l e s s than 6 months of a g e , often in t h e presence of maternal antibody.
We
h a v e d i s s e c t e d t h e maternal antibody donation t o determine t h e q u a n t i t a t i v e d i f f e r e n c e s t h a t may account f o r variations in t h e s e v e r i t y of p r i m a r y RSV infections.
Using a c a s e control design (N=42), we measured RSV glycoprotein ( F and G) a n t i b o d i e s in c o r d s e r a obtained from infants hospitalized with RSV during t h e i r f i r s t y e a r of l i f e and nonhospitalized DOB matched controls.
Using EIA, no difference was found between p a i r s with regard t o t o t a l F antibodies.
However, controls had a significantly h i g h e r functional F antibody t i t e r a s measured by an anti-syncytia a s s a y ( p < 0 . 0 0 1 ) . Controls a l s o had a significantly h i g h e r t o t a l G t i t e r ( p < 0 . 0 0 1 ) , which was reflected in a significantly h i g h e r neutralization t i t e r (p<0.02) when compared t o hospitalized infants.
The d a t a suggest protection from s e v e r e d i s e a s e during t h e f i r s t y e a r of l i f e c o r r e l a t e s w i t h t h e magnitude of t h e antibody response t o t h e G glycoprotein f o r conferring neutralization and t o t h e F glycoprotein f o r conferring inhibition of s y n c y t i a . In order to isolate the active agent in these cultures, hydrophilic molecules were solubilized by autoclaving the ceLls in distilled water and testing the resulting aqueous extract. Strongly positive results were obtained. Because previous work showed that the cascade could be activated by synthetic @-glucans, we isolated naturally occurring p-glucans f r m the fungi, using the alkaline Fehling's solution tehnique of Peat and of Grimcke. P-glucans isolated in this fashion activated the cascade.
ACTIVATION BY C A N D I N B-GLUCANS
By contrast, c m r c i a l l y prepared 4glucans (glycogen, starch) had no effect.
In contrast with these findings, cannercial amebocyte lysates of the American horseshoe crab polyphmius gave equivocal and inconsistent results.
'he possibility that our results were due to contaminating endotoxin was excluded in two ways. First, when quantities of endotoxin were deliberately added to our preparations in reconstruction experiments they were undetectable after our washing procedures. Second, our preparations did not react appreciably with a Tachypleus preparation (Seikagaku Kogyo, Tokyo) made specific for endotofin by the renoval of an alternate activation pathway. It i s postulated that it i s this pathway that i s activated by fungal /3-glucims. Clinical applications based on this differential activation of the cascade by fungal and bacterial products are currently being explored.
